drugset
drugset / Trial / NCT05531942

Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke

NCT05531942 ↗

Phase 2/3 Unknown 70 enrolled Shanghai Yueyang Integrated Medicine Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(100mg once/day D1-D14) in combination, while the other half will receive aspirin(100mg once/day D1-D14).

Timeline

Start
2021-01-01
Primary completion
2023-10-01
Completion
2023-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ginkgo Diterpene Lactone Meglumine Injection Unknown 25 mg Intravenous
Comparator Aspirin Small molecule 100 mg —

Indications

ischemic stroke